GO
Loading...

Takeover Bids

More

  • NEW YORK, June 16- Morgan Stanley, an adviser to Valeant Pharmaceuticals International Inc in its $53 billion hostile bid for Allergan Inc, initially tried to get hired by Allergan and in its pitch called the unsolicited bidder a "house of cards", according to Allergan.

  • TOKYO, June 16- Mitsubishi Heavy Industries' involvement in Siemens' bid for the power assets of France's Alstom fits in with the Japanese company's plans to build a global presence after a recent major reorganization of its business.

  • June 13- William Ackman's Pershing Square Capital Management on Friday it filed a lawsuit against Allergan Inc seeking confirmation that its request to hold a special meeting of Allergan shareholders would not trigger poison pill takeover defense. Ackman and Valeant Pharmaceuticals International are pursuing in a hostile takeover of Allergan.

  • *Mitsubishi and France would take equal stakes in Alstom- unions. MUNICH/ PARIS, June 13- Germany's Siemens and Japan's Mitsubishi Heavy Industries are putting the finishing touches on a joint offer for Alstom's turbine businesses that includes a cash element of roughly 9 billion euros, sources close to the bidders said.

  • Siemens and Mitsubishi finalize Alstom offer Friday, 13 Jun 2014 | 12:33 PM ET

    *Siemens would acquire gas turbines from Alstom, sources say. MUNICH/ PARIS, June 13- Germany's Siemens and Japan's Mitsubishi Heavy Industries are putting the finishing touches on a joint offer for Alstom's turbine businesses that includes a cash element of roughly 9 billion euros, sources close to the bidders said.

  • Siemens and Mitsubishi finalise Alstom offer Friday, 13 Jun 2014 | 12:33 PM ET

    *Siemens would acquire gas turbines from Alstom, sources say. MUNICH/ PARIS, June 13- Germany's Siemens and Japan's Mitsubishi Heavy Industries are putting the finishing touches on a joint offer for Alstom's turbine businesses that includes a cash element of roughly 9 billion euros, sources close to the bidders said.

  • A takeover bid that caused much consternation didn't even go through after AstraZeneca PLC said "no thanks" to Pfizer Inc. in April. The episode caused Eric Sappenfield, co-manager of the John Hancock Global Shareholder Yield Fund, to turn cautious on Pfizer, although he still owns some.

  • June 10- Botox maker Allergan Inc on Tuesday rejected a sweetened $53 billion takeover offer from Valeant Pharmaceuticals International and activist investor William Ackman, reiterating that it undervalues the company and is too risky for shareholders.

  • Medtronic CEO: Focused on organic growth     Thursday, 5 Jun 2014 | 3:20 PM ET

    Omar Ishrak, Medtronic chairman & CEO, discusses the state of the health care industry and explains the extensive M&A activity happening in the sector.

  • MELBOURNE, June 5- China's Baosteel Resources and its Australian bidding partner on Thursday set a deadline of July 11 on their $1 billion offer for Aquila Resources Ltd, which they are chasing for its iron ore and coal projects.

  • Unusual options around Hillshire Brands     Tuesday, 3 Jun 2014 | 12:45 PM ET

    FMHR trader Pete Najarian takes a close look at unusual activity in options for Hillshire Brands, and the action in its stock as takeover talks continue.

  • Fight for Hillshire     Tuesday, 3 Jun 2014 | 9:02 AM ET

    Pilgrim's Pride is sweetening its takeover offer for Hillshire Brands. CNBC's Jim Cramer and David Faber discuss the "insane" bidding for Hillshire.

  • June 2- Valeant Pharmaceuticals Inc on Monday prepared to take its $53.8 billion takeover bid for Allergan Inc directly to the Botox maker's shareholders in a battle that could last late into the year. The fight escalated when Valeant ally Pershing Square, a hedge fund that owns 9.7 percent of Allergan, called for a meeting to replace the company's board.

  • June 2- U.S.-based Sterigenics International has sweetened its takeover offer for Nordion Inc, the Canadian medical isotope producer, to $805 million after a previous bid failed to attract enough shareholder support, Nordion said on Monday.

  • June 2- Valeant Pharmaceuticals Inc on Monday prepared to take its $53.8 billion takeover bid for Allergan Inc directly to the Botox maker's shareholders, and ally Pershing Square called for a meeting to turn over the target company's board.

  • Mario Gabelli, Gamco Investors chairman & CEO, shares his thoughts on how to play the social media, e-commerce, and natural gas space.

  • Insurer Endurance raises takeover offer for Aspen Monday, 2 Jun 2014 | 7:36 AM ET

    June 2- Insurer Endurance Specialty Holdings increased its offer for Aspen Insurance Holdings by $2.00 to $49.50 per share after its initial bid was rejected.

  • Gabelli eyes takeover targets     Monday, 2 Jun 2014 | 7:16 AM ET

    Mario Gabelli, Gamco Investors chairman & CEO, explains why he is watching shares of Protective Life, Interpublic Group, and Hillshire Brands.

  • Laval, Quebec- based Valeant said it would pay $72 in cash- up from $58.30 on Wednesday- and 0.83 share of Valeant stock for each Allergan share. The revised, unsolicited offer was triggered by Pershing Square, the hedge fund controlled by Bill Ackman that is Allergan's biggest shareholder, agreeing to take only stock in Valeant for its Allergan shares.

  • Valeant said it would pay $72 in cash- up from $58.30 on Wednesday- and 0.83 share of Valeant stock for each Allergan share. The offer was made possible by Pershing Square, the hedge fund controlled by Bill Ackman that is Allergan's biggest shareholder, agreeing to take only stock in Valeant for its Allergan shares and receive no cash.